Acalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT)

Clinical trial NCT04716075 · COMPLETED

Trial details

NCT number: NCT04716075
Sponsor: Polish Lymphoma Research Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia Chronic Graft-versus-host-disease Mantle Cell Lymphoma Adverse Event Response Rate

Start date: 2019-08-19
Primary completion: 2024-06-30
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.